Sonendo (SONX) Stock Price, News & Analysis

Company Overview

Sonendo, Inc., a commercial-stage medical technology company, develops, manufactures, and commercializes devices for root canal therapy in the United States and Canada. It provides GentleWave, a tooth decay treatment, a technology platform designed for cleaning and disinfecting the microscopic spaces within teeth without the need to remove tooth structure. The company also offers SoundSeal, a material used to build and create a sealing platform on the top of the crown; and Sonendo-branded liquid solution of ethylenediaminetetraacetic acid EDTA that is used to help debride and disinfect the root canal system. In addition, it provides The Digital Office, a practice management software to enable an integrated digital office for dental practitioners. The company was formerly known as Dentatek Corporation and changed its name to Sonendo, Inc. in March 2011. The company was incorporated in 2006 and is headquartered in Laguna Hills, California.

Key Stats

• Today's Range: $1.88 to $2.33
• 50-Day Range: $0.03 to $3.70
• 52-Week Range: $1.00 to $80.00
• Volume: 1,993 shs
• Average Volume: 2,046 shs
• Market Capitalization: $937,200.00
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: Hold

SONX Stock Analysis - Frequently Asked Questions

How have SONX shares performed this year?

Sonendo's stock was trading at $0.21 at the beginning of 2024. Since then, SONX stock has increased by 947.6% and is now trading at $2.20.
View the best growth stocks for 2024 here.

How were Sonendo's earnings last quarter?

Sonendo, Inc. (NYSE:SONX) released its earnings results on Wednesday, August, 7th. The company reported ($0.08) earnings per share for the quarter, beating the consensus estimate of ($0.12) by $0.04. The firm had revenue of $8.31 million for the quarter, compared to the consensus estimate of $7.60 million. Sonendo had a negative net margin of 92.74% and a negative trailing twelve-month return on equity of 184.01%.

When did Sonendo IPO?

Sonendo (SONX) raised $125 million in an initial public offering (IPO) on Friday, October 29th 2021. The company issued 7,800,000 shares at $15.00-$17.00 per share.

How do I buy shares of Sonendo?

Shares of SONX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

What other stocks do shareholders of Sonendo own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Sonendo investors own include Avino Silver & Gold Mines (ASM), Avino Silver & Gold Mines (ASM), Taiwan Semiconductor Manufacturing (TSM), XPeng (XPEV), nCino (NCNO), PayPal (PYPL) and Construction Partners (ROAD).

Company Calendar

• Last Earnings: 8/07/2024
• Today: 12/21/2024
• Fiscal Year End: 12/31/2024

Industry, Sector and Symbol

• Stock Exchange: NYSE
• Sector: Medical
• Industry: Dental equipment & supplies
• Sub-Industry: Medical Equipment
• Current Symbol: NYSE:SONX
• CUSIP: N/A
• CIK: 1407973
• Web: www.sonendo.com
• Phone: 949-766-3636
• Fax: N/A
• Employees: 250
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): ($69.77)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: $-60,920,000.00
• Net Margins: -92.74%
• Pretax Margin: -105.16%
• Return on Equity: -184.01%
• Return on Assets: -68.60%

Debt

• Debt-to-Equity Ratio: 0.55
• Current Ratio: 1.82
• Quick Ratio: 1.22

Sales & Book Value

• Annual Sales: $44.40 million
• Price / Sales: 0.02
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $89.42 per share
• Price / Book: 0.02

Miscellaneous

• Outstanding Shares: 426,000
• Free Float: 392,000
• Market Cap: $937,200.00
• Optionable: Not Optionable
• Beta: 1.14